Advertisement

Methoxyflurane and Teflurane

  • Alan van Poznak
Part of the Handbuch der experimentellen Pharmakologie/Handbook of Experimental Pharmacology book series (HEP, volume 30)

Abstract

The story of the synthesis of methoxyflurane and teflurane is different from the usual sequence of events in the synthesis and evaluation of a drug. The usual situation is that a series of chemical compounds is synthesized by a chemist, examined by a pharmacologist for possible useful activity, further examined by a clinical pharmacologist for desirable activity in human beings and then ultimately distributed to the specialist clinicians who will use the drug in their practice.

Keywords

Diethyl Ether Anesthetic Agent Federation Proc Motor Nerve Terminal Inhalation Anesthetic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Artusio, J. F., Jr.: Clinical evaluation of methoxyflurane in man. Federation Proc. 19, 272 (1960).Google Scholar
  2. Artusio, J. F., Jr., Hunt, R. E., Tiers, F. M., Alexander, M.: A clinical evaluation of methoxyflurane in man. Anesthesiology 21, 512 (1960).PubMedCrossRefGoogle Scholar
  3. Artusio, J. F., Jr., van Poznak, A.: The concept of intermediate potency. Far East J. Anesth. 2, 27 (1958).Google Scholar
  4. Artusio, J. F., Jr., van Poznak, A., Anesthetic properties of a series of fluorinated compounds. I. Fluorinated hydrocarbons. Toxicol. Appl. Pharmacol. 2, 363–373 (1960).PubMedCrossRefGoogle Scholar
  5. Artusio, J. F., Jr., van Poznak, A., Beirne, J. H., Merin, R. G.: A clinical evaluation of teflurane: A preliminary report. (Presented at 45th Annual Meeting of Federation of American Societies for Experimental Biology, April, 1961.) Abstract in Federation Proc. 20, 312c, Pt. 1.Google Scholar
  6. Bagwell, E. E., Woods, E. F.: Cardiovascular effects of methoxyflurane. Anesthesiology 23 51 (1962).PubMedCrossRefGoogle Scholar
  7. Bagwell, E. E., Woods, E. F., Gadsden, R. H.: Blood levels and cardiovascular dynamics during methoxyflurane inhalation in dogs. Anesthesiology 23, 243 (1962).PubMedCrossRefGoogle Scholar
  8. Bagwell, E. E., Woods, E. F., Mahaffey, J.: Cardiovascular effects of methoxyflurane in dogs. Federation Proc. 20, 313 (1961).Google Scholar
  9. Bamforth, B. J., Siebecker, K. L., Kraemer, R., Orth, O. S.: Effect of epinephrine on the dog heart during methoxyflurane anesthesia. Anesthesiology 22, 355 (1961).CrossRefGoogle Scholar
  10. Cale, J. O., Parks, C. R., Jenkins, M. T.: Hepatic and renal effects of methoxyflurane in dogs. Anesthesiology 23, 248 (1962).PubMedCrossRefGoogle Scholar
  11. Campbell, M. W., Hvollboll, A. P., Brechner, V. L.: Penthrane: a clinical evaluation in 50 cases.Anesthesia & Analgesia 41, 134 (1962).Google Scholar
  12. Chenoweth, M. B., Robertson, D. N., Erley, D. S., Golhke, R.: Blood and tissue levels of ether, chloroform, halothane and methoxyflurane in dogs. Anesthesiology 23, 101 (1962).PubMedCrossRefGoogle Scholar
  13. Dobkin, A. B., Fedoruk, S.: Comparison of the cardiovascular, respiratory, and metabolic effects of methoxyflurane and halothane in dogs. Anesthesiology 22, 344 (1961).Google Scholar
  14. Dobkin, A. B., Israel, J. S.: The effect of SA-97, perphenazine, and hydroxyzine on epinephrine-induced cardiac arrhythmias during methoxyflurane anaesthesia in dogs. Canad. Aiaesth. Soc. J. 9, 36 (1962).CrossRefGoogle Scholar
  15. Edelist, G., Singer, M. M., Eger II., E. I.: Solubility coefficients of teflurane in various bio-logical media. Anesthesiology 25, 223–225 (1964).Google Scholar
  16. Fabian, L. W.: The effect of three fluorinated compounds on the kidney. (Presented at the Annual Meeting of University Anesthetists, January, 1965.)Google Scholar
  17. French, A. B., Barss, T. P., Fairlie, C. S., Bengle, A. L., Jr., Jones, C. M., Linton, R. R., Beecher, H. K.: Metabolic effects of anesthesia in man. V. A comparison of the effects of ether and cyclopropane anesthesia on the abnormal liver. Ann. Surg. 135, 145 (1952).PubMedCrossRefGoogle Scholar
  18. Galindo, A., Brindle, F. B., Gilbert, R. G. B.: Renal and hepatic function during teflurane anesthesia.Google Scholar
  19. Hudon, R.: Methoxyflurane. Canad. Anaesth. Soc. J. 8, 544 (1961).PubMedCrossRefGoogle Scholar
  20. Hunt, R. E., Artusio, J. F., Jr., van Poznak, A.: Effect of clinical anesthesia using DA-759 on liver function. Paper presented at Post-graduate Assembly in Anesthesiology, New York, 1959.Google Scholar
  21. Israel, J. S., Dobkin, A. B., Robidoux, H. J., Jr.: The effect of sympathetic blockade of hyperventilation on epinephrine-induced cardiac arrhythmias during anaesthesia with halothane and methoxyflurane. Canad. Anaesth. Sioc. J. 9, 125 (1962).CrossRefGoogle Scholar
  22. Jumes, M. G., Siebecker, K. L.: Hepatic and respiratory effects of methoxyflurane. Paper presented at Postgraduate Assembly in Anesthesiology. New York, December 1960.Google Scholar
  23. Knox, P. R., North, W. C., Stephen, C. R.: Methoxyflurane — a clinical evaluation. Anesthesiology 23, 238 (1962).PubMedCrossRefGoogle Scholar
  24. Kuzucu, E.: Methoxyflurane, tetracycline, and renal failure. J. Am. Med. Assoc. 211,1162 to 1164 (1970).CrossRefGoogle Scholar
  25. Meek, W. J., Hathaway, H. R., Orth, O. S.: Effects of ether, chloroform and cyclopropane on cardiac automaticity. J. Pharmacol. Exptl Therap. 61, 240 (1937).Google Scholar
  26. Millar, R. A., Morris, M. E.: A study of methoxyflurane anesthesia. Canad. Anaesth. Soc. J. 8, 210 (1961).PubMedCrossRefGoogle Scholar
  27. Ngai, S. H., Hanks, E. C.: Effect of methoxyflurane on electromyogram, neuromuscular transmission, and spinal reflex. Paper presented at Annual Meeting, American Society of Anesthesiologists, October, 1961.Google Scholar
  28. Ngai, S. H., Hanks, E. C., Farhie, S. E.: Effects of anesthetics on neuromuscular transmission and somatic reflexes. Anesthesiology 26, 162–167 (1965).PubMedCrossRefGoogle Scholar
  29. North, W. C.: Cardiovascular effect of teflurane. Federation Proc. 21, 329 c (1962).Google Scholar
  30. North, W. C., Knox, P. R.: The influence of methoxyflurane upon the cardiovascular response to epinephrine. Federation Proc. 20, 312 (1961).Google Scholar
  31. North, W. C., Vartanian, V., Stephen, C. R.: Respiratory, circulatory, and hepatic effects of methoxyflurane in dogs. Anesthesiology 22, 138 (1961).CrossRefGoogle Scholar
  32. Power, D. J.: McGill University experiences with methoxyflurane. Canad. Anaesth. Soc. J. 8, 488 (1961).PubMedCrossRefGoogle Scholar
  33. Riker, W. F., Werner, G., Roberts, J., Kuperman, A.: Pharmacologic evidence for the existence of a presynaptic event in neuromuscular transmission. J. Pharmacol. Exptl Therap. 125, 150–158 (1959).Google Scholar
  34. Siebecker, K. L., Jumes, M. G., Bamforth, B. J., Orth, O. S.: The respiratory effects of methoxyflurane on dog and man. Anesthesiology 22, 143 (1961).CrossRefGoogle Scholar
  35. Smith, B. E., Gaub, M. L., Moya, F.: Investigations into the teratogenic effects of anesthetic agents: The fluorinated agents. Anesthesiology 25, 260 (1965).Google Scholar
  36. Standaert, F. G.: The action of d-tubocurarine on the motor nerve terminal. J. Pharmacol. Exptl Therap. 148, 181, 186 (1964).Google Scholar
  37. Thompson, R., Light, G., Holaday, D. A.: Methoxyflurane anesthesia: A clinical appraisal. Anesthesia &Analgesia 41, 225 (1962).Google Scholar
  38. van Dyke, R. A.: On the fate of chloroform (Editorial). Anesthesiology 257.Google Scholar
  39. van Dyke, R. A., Chenoweth, M. B.: Metabolism of volatile anesthetics (Review). Anesthesiology 26, 348 to 357 (1965).CrossRefGoogle Scholar
  40. van Poznak, A.: Laboratory and clinical investigations of teflurane. J. Amer. Ass. Nurse Anesthetist 32, 38–42 (1964).Google Scholar
  41. van Poznak, A., Artusio, J. F., Jr.: Series of fluorinated ethers. Federation Proc. 19, 273 (1960).Google Scholar
  42. van Poznak, A., Anesthetic properties of a series of fluorinated compounds. I. Fluorinated hydrocarbons. Toxicol. Appl. Pharmacol. 2, 363 (1960).CrossRefGoogle Scholar
  43. van Poznak, A., Anesthetic properties of a series of fluorinated compounds. II. Fluorinated ethers. Toxicol. Appl. Pharmacol. 2, 374 (1960).CrossRefGoogle Scholar
  44. van Poznak, A., Hou, B.: Neuromuscular effects of methoxyflurane. Federation Proc. 28, 419 (1969).Google Scholar
  45. van Poznak, A., Ray, B. S., Artusio, J. F., Jr.: Methoxyflurane as an anesthetic for neurological surgery. J. Neurosurg. 17, 477 (1960).PubMedCrossRefGoogle Scholar
  46. Warner, W. A., Orth, O. S.: Laboratory investigation of teflurane l,l,l,2-tetrafluoro-2- bromoethane (DA-708). Federation Proc. 21, 325a (1962).Google Scholar
  47. Warner, W. A.,Weber, D. L., Layton, J. M.: Laboratory investigation of teflurane l,l,l,2-tetrafluoro-2- bromoethane (DA-708). Anesthesia & Analgesia 46, 32–38 (1967).Google Scholar
  48. Wasmuth, C. E., Greig, J. H., Homi, J., Moraca, J., Isil, N. H., Bitt, E. M., Hale, D. E.: Methoxyflurane — a new anesthetic agent. Cleveland Clinic Quart. 27, 174 (1960).Google Scholar
  49. Wyant, G. M., Chang, C. A., Rapicavoli, E.: Methoxyflurane (Penthrane): a laboratory and clinical study. Canad. Aanseth. Soc. J. 8, 477 (1961).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Berlin · Heidelberg 1972

Authors and Affiliations

  • Alan van Poznak

There are no affiliations available

Personalised recommendations